179 related articles for article (PubMed ID: 16271083)
1. Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.
Nakayama H; Sano T; Motegi A; Oyama T; Nakajima T
Pathol Int; 2005 Nov; 55(11):707-15. PubMed ID: 16271083
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers.
Horie-Inoue K; Inoue S
Semin Cancer Biol; 2006 Jun; 16(3):235-9. PubMed ID: 16682214
[TBL] [Abstract][Full Text] [Related]
4. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth.
Urano T; Saito T; Tsukui T; Fujita M; Hosoi T; Muramatsu M; Ouchi Y; Inoue S
Nature; 2002 Jun; 417(6891):871-5. PubMed ID: 12075357
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
[TBL] [Abstract][Full Text] [Related]
7. [Expression and relationship of Ezh2, Runx3 and caspase-3 in endometrial adenocarcinoma].
Guo ZL; Chen K; Wang XQ; Hu W
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):387-91. PubMed ID: 21914347
[TBL] [Abstract][Full Text] [Related]
8. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3 sigma possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid.
Ito Y; Miyoshi E; Uda E; Yoshida H; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
Cancer Lett; 2003 Oct; 200(2):161-6. PubMed ID: 14568170
[TBL] [Abstract][Full Text] [Related]
10. Retinoid receptors in the human endometrium and its disorders: a possible modulator of 17 beta-hydroxysteroid dehydrogenase.
Ito K; Suzuki T; Moriya T; Utsunomiya H; Sugawara A; Konno R; Sato S; Sasano H
J Clin Endocrinol Metab; 2001 Jun; 86(6):2721-7. PubMed ID: 11397877
[TBL] [Abstract][Full Text] [Related]
11. Expression of Efp, VEGF and bFGF in normal, hyperplastic and malignant endometrial tissue.
Dai H; Zhao S; Xu L; Chen A; Dai S
Oncol Rep; 2010 Mar; 23(3):795-9. PubMed ID: 20127022
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathologic significance of the loss of BAF250a (ARID1A) expression in endometrial carcinoma.
Zhang ZM; Xiao S; Sun GY; Liu YP; Zhang FH; Yang HF; Li J; Qiu HB; Liu Y; Zhang C; Kang S; Shan BE
Int J Gynecol Cancer; 2014 Mar; 24(3):534-40. PubMed ID: 24557437
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic analysis of hormone-sensitive patient-derived endometrial cancer spheroid culture defines Efp as a proliferation modulator.
Yang C; Ikeda K; Horie-Inoue K; Sato W; Hasegawa K; Takeda S; Itakura A; Inoue S
Biochem Biophys Res Commun; 2021 Apr; 548():204-210. PubMed ID: 33647797
[TBL] [Abstract][Full Text] [Related]
14. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins.
Lee MH; Lozano G
Semin Cancer Biol; 2006 Jun; 16(3):225-34. PubMed ID: 16697215
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
Segawa T; Sasagawa T; Saijoh K; Inoue M
Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
[TBL] [Abstract][Full Text] [Related]
18. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
19. Quantitative detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy.
Martínez-Galán J; Torres B; Del Moral R; Muñoz-Gámez JA; Martín-Oliva D; Villalobos M; Núñez MI; Luna Jde D; Oliver FJ; Ruiz de Almodóvar JM
Cancer Biol Ther; 2008 Jun; 7(6):958-65. PubMed ID: 18379196
[TBL] [Abstract][Full Text] [Related]
20. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
